QIAGEN NV (QGEN)
50.20
-0.14
(-0.28%)
USD |
NYSE |
Oct 30, 16:00
50.17
-0.03
(-0.06%)
After-Hours: 20:00
QIAGEN Cash from Operations (Quarterly) : 200.69M for June 30, 2026
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 200.69M |
| March 31, 2026 | 100.63M |
| December 31, 2025 | 188.13M |
| September 30, 2025 | 165.02M |
| June 30, 2025 | 161.44M |
| March 31, 2025 | 139.74M |
| December 31, 2024 | 191.51M |
| September 30, 2024 | 182.35M |
| June 30, 2024 | 166.62M |
| March 31, 2024 | 133.08M |
| December 31, 2023 | 151.37M |
| September 30, 2023 | 124.68M |
| June 30, 2023 | 111.48M |
| March 31, 2023 | 71.93M |
| December 31, 2022 | 124.32M |
| September 30, 2022 | 211.58M |
| June 30, 2022 | 171.95M |
| March 31, 2022 | 207.41M |
| December 31, 2021 | 198.46M |
| September 30, 2021 | 155.52M |
| June 30, 2021 | 156.40M |
| March 31, 2021 | 128.63M |
| December 31, 2020 | 269.71M |
| September 30, 2020 | 37.50M |
| June 30, 2020 | 134.68M |
| Date | Value |
|---|---|
| March 31, 2020 | 15.91M |
| December 31, 2019 | 109.43M |
| September 30, 2019 | 94.20M |
| June 30, 2019 | 82.48M |
| March 31, 2019 | 44.73M |
| December 31, 2018 | 110.51M |
| September 30, 2018 | 82.75M |
| June 30, 2018 | 118.02M |
| March 31, 2018 | 48.22M |
| December 31, 2017 | 76.07M |
| September 30, 2017 | 81.20M |
| June 30, 2017 | 69.36M |
| March 31, 2017 | 60.16M |
| December 31, 2016 | 100.02M |
| September 30, 2016 | 93.81M |
| June 30, 2016 | 99.08M |
| March 31, 2016 | 48.69M |
| December 31, 2015 | 86.76M |
| September 30, 2015 | 96.06M |
| June 30, 2015 | 71.83M |
| March 31, 2015 | 62.84M |
| December 31, 2014 | 86.51M |
| September 30, 2014 | 89.73M |
| June 30, 2014 | 73.60M |
| March 31, 2014 | 45.61M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Illumina, Inc. | 201.00M |
| Thermo Fisher Scientific, Inc. | 2.55B |
| Bio-Rad Laboratories, Inc. | 98.70M |
| Waters Corp. | 201.00M |
| Agilent Technologies, Inc. | 519.00M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -70.26M |
| Cash from Financing (Quarterly) | -8.47M |
| Free Cash Flow | 440.60M |
| Free Cash Flow Per Share (Quarterly) | 0.757 |
| Free Cash Flow to Equity (Quarterly) | 160.26M |
| Free Cash Flow to Firm (Quarterly) | 165.17M |
| Free Cash Flow Yield | 4.22% |